Know Cancer

or
forgot password
  • cancer clinical trials in new brunswick, NJ

  • Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Colorectal Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    UMDNJ - Robert Wood Johnson University Hospital
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Lymphoma, Lymphoproliferative Disorder
    Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Leukemia
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Internal Radiation Therapy of the Breast in Treating Women With Early-Stage Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Brain and Central Nervous System Tumors
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
    Cancer Institute of New Jersey 195 Little Albany Street
    New Brunswick, New Jersey 08903-2681
    Multiple Myeloma
    Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Peripheral T-cell Lymphoma
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Saint Peter's University Hospital
    New Brunswick, New Jersey 08901-1780
    Kidney Cancer
    A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Metastatic Pancreatic Adenocarcinoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Estrogen Receptor-positive Breast Cancer, Stage III Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Leukemia
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Saint Peter's University Hospital
    New Brunswick, New Jersey 08901-1780
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    UMDNJ - Robert Wood Johnson University Hospital
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Thyroid Cancer, Stage I Follicular Thyroid Cancer, Stage I Papillary Thyroid Cancer, Stage II Follicular Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer
    Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Prostate Cancer
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    UMDNJ - Robert Wood Johnson University Hospital
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Glioblastoma Multiforme
    Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Prostate Cancer
    Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Colorectal Cancer Metastatic
    Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma, Unspecified Adult Solid Tumor, Protocol Specific
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Fungal Infection, Leukemia, Neutropenia
    PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
    Cancer Institute of New Jersey SC
    New Brunswick, New Jersey 08901
    Castration-resistant Prostate Cancer,, Metastatic Breast Cancer, Uterine Leiomyoma
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Robert Wood Johnson/Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    Zarnestra in Newly Diagnosed Acute Myelogenous Leukemia (AML)With 2 Gene Expression Signature Ratio
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Acute Myelogenous Leukemia
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    UMDNJ - Robert Wood Johnson University Hospital
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma, Mucinous Ductal Breast Carcinoma, Papillary Ductal Breast Carcinoma, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Tubular Ductal Breast Carcinoma
    Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Breast Cancer
    Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
    University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08901
    Smoking Cessation
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    Local Institution
    New Brunswick, New Jersey
    Leukemia, Pediatric
    Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors or Prostate or Kidney Cancer
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Recurrent Prostate Cancer, Recurrent Renal Cell Cancer, Stage III Prostate Cancer, Stage III Renal Cell Cancer, Stage IV Prostate Cancer, Stage IV Renal Cell Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Prostate Cancer